Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- STSA
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Satsuma Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 36.47M
- Ent value
- 22.77M
- Price/Sales
- -
- Price/Book
- 0.97
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 23.22%
- 1 year return
- -67.55%
- 3 year return
- -66.25%
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
STSA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.97 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 33.15M |
| EPS (TTM) | -1.91 |
| FCF per share (TTM) | -1.49 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -66.17M |
| Net income (TTM) | -63.33M |
| EPS (TTM) | -1.91 |
| EPS (1y forward) | -0.85 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 19.53M |
| Net receivables | 0.00 |
| Total current assets | 43.38M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 43.48M |
| Accounts payable | 874.00K |
| Short/Current long term debt | 116.00K |
| Total current liabilities | 5.83M |
| Total liabilities | 5.83M |
| Shareholder's equity | 37.65M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -48.58M |
| Capital expenditures (TTM) | 783.00K |
| Free cash flow (TTM) | -49.37M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -168.23% |
| Return on Assets | -145.67% |
| Return on Invested Capital | -167.71% |
| Cash Return on Invested Capital | -130.72% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| STSA | S&P500 | |
| Current price drop from All-time high | -96.83% | -10.01% |
| Highest price drop | -98.24% | -56.47% |
| Date of highest drop | 16 Nov 2022 | 9 Mar 2009 |
| Avg drop from high | -70.44% | -10.99% |
| Avg time to new high | 47 days | 12 days |
| Max time to new high | 748 days | 1805 days |
COMPANY DETAILS
Marketcap
36.47M
Marketcap category
Small-cap
Description
Satsuma Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops novel therapeutic products for the acute treatment of migraines. The company's product candidature includes STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. As of June 8, 2023, Satsuma Pharmaceuticals, Inc. operates as a subsidiary of Shin Nippon Biomedical Laboratories, Ltd.
Employees
25
Website
Investor relations
-
SEC filings
CEO
John A. Kollins
Country
USA
City
San Francisco
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner